
Expanding LNP Applications Beyond mRNA Vaccines
Table of contents

Lipid nanoparticles (LNPs) have transformed how we deliver mRNA. But their role in modern medicine is just beginning.
In this new expert-authored article, BioCina explores how LNPs are being engineered to deliver a wider range of payloads, including siRNA, gene-editing systems, peptides, and small molecules, across therapeutic areas from oncology to neurology.
In this article, learn about:
- Strategies to optimize LNP targeting, biodistribution, and stability
- Applications in gene silencing, CAR-T, chronic disease, and more
- How thermal-stable LNPs can improve global access and reduce logistics costs
- BioCina’s integrated capabilities across mRNA, pDNA, LNPs, and GMP production
Discover how a platform born for vaccines is now powering the next generation of advanced therapies.
Access the article here
Share Article

